China: Drug regulator tightens ties to agencies in Hong Kong and Macau

15-05-2019

China: Drug regulator tightens ties to agencies in Hong Kong and Macau

(Source: RAPS 2019-05-14)

China’s National Medical Products Administration (NMPA) has signed a cooperation agreement with its counterparts in Hong Kong and Macau. The agreement positions the agencies to share regulatory information and cooperate on standards.

Chinese officials framed the agreement as a continuation of the “one country, two systems” approach it began to pursue in the 1980s to reunify the country without imposing economic and administrative systems on Hong Kong and Macau. The model led Macau and, particularly, Hong Kong to develop standalone regulatory systems.

Now, NMPA wants to deepen its cooperation with the neighboring medicine regulatory agencies. The statement to disclose the news highlights personnel training, recalls, safety alerts and the exchange of regulatory information as areas covered by the agreement.

NMPA also said meeting with officials from Hong Kong and Macao gave it a chance to hear their views on China’s plans to create a Greater Bay Area that will involve all three territories. The plans for the development include the creation of a science and technology innovation center.

To continue reading this article please go to RAPS

New Article